Next 10 |
home / stock / wxxwy / wxxwy news
2024-04-25 03:00:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. The Artisan Developing World Fund returned 11.09% for the quarter ended March 31, 202...
2024-04-24 15:27:29 ET Summary The market's opinion of WuXi Biologics' 2024 financial prospects is negative, taking into account elevated interest rates and geopolitical risk factors. Recent share repurchases support the view that WXXWY's current valuations have factored in the co...
2024-04-18 12:40:00 ET Summary Laughing Water Capital is a concentrated, long biased investment partnership open to accredited investors. Our interests are fully aligned with our partners as nearly all of our personal wealth is invested in our strategy. Laughing Water Capital retu...
2024-03-24 07:15:00 ET Summary Shanghai WuXi Biologics (HK: 2269) has broken ground on a $1.4 billion facility in Singapore, the first CRDMO to offer end-to-end biologics research, development and manufacturing in the city-state. Novo Nordisk announced plans to invest $556 million...
2024-03-14 07:20:30 ET More on WuXi AppTec, WuXi AppTec, etc. Potential U.S. Targeting Casts Shadow Over WuXi AppTec Family WuXi Biologics: Recent Share Price Recovery Isn't Sustainable Historical earnings data for WuXi AppTec Dividend scorecard for WuXi AppT...
2024-02-08 07:41:00 ET Summary WuXi AppTec, which could be banned from doing business with federal agencies under proposed legislation, derived 65% of its revenue from the U.S. in the first half of last year. The provider of outsourced services to drug makers said it has never spo...
2024-02-07 11:28:54 ET More on I-Mab Biopharma Seeking Alpha’s Quant Rating on I-Mab Biopharma Historical earnings data for I-Mab Biopharma Financial information for I-Mab Biopharma Read the full article on Seeking Alpha For further details see...
2024-02-01 03:00:00 ET Summary Beijing is rolling out a host of measures to boost economic growth and support sagging stock markets. The policies helped Hong Kong’s Hang Seng jump 4.2% last week, breaking a January losing streak. Under a new policy, market valuation will be...
2024-01-18 00:00:00 ET Summary Emerging markets equities saw positive performance in 4Q 2023, driven by valuation re-rating and currency strength. Taiwan Region, India and South Korea boosted benchmark returns, while China underperformed. Brazil remains the Strategy’s l...
2024-01-08 06:37:00 ET More on Wuxi Biologics ADR WuXi Bio Prescribes Share Buyback To Relieve Revenue Pain WuXi Biologics: Holiday Fire Sale For Leading CRDMO Historical earnings data for Wuxi Biologics ADR Financial information for Wuxi Biologics ADR ...
News, Short Squeeze, Breakout and More Instantly...
Wuxi Biologics Cayman Inc ADR Company Name:
WXXWY Stock Symbol:
OTCMKTS Market:
Amid the ongoing scrutiny from Congress, WuXi AppTec and its affiliates face another setback as the Biotechnology Innovation Organization...
SHANGHAI, Jan. 10, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufa...
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale PR Newswire By leveraging WuXiUP TM , WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing ...